These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 9473790)
1. Does the concentration of alpha 1-proteinase inhibitor reflect the transformation of liver cirrhosis to liver carcinoma? Dabrowska M; Mantur M; Panasiuk A; Prokopowicz J Neoplasma; 1997; 44(5):305-7. PubMed ID: 9473790 [TBL] [Abstract][Full Text] [Related]
2. Cytokine evaluation in liver cirrhosis and hepatocellular carcinoma. Cheng KS; Tang HL; Chou FT; Chou JW; Hsu CH; Yu CJ; Kao ST; Li TC Hepatogastroenterology; 2009; 56(93):1105-10. PubMed ID: 19760951 [TBL] [Abstract][Full Text] [Related]
3. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis. Tarao K; Fujiyama S; Ohkawa S; Miyakawa K; Tamai S; Hirokawa S; Masaki T; Tanaka K Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):164-9. PubMed ID: 15668491 [TBL] [Abstract][Full Text] [Related]
4. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis. Shimizu A; Shiraki K; Ito T; Sugimoto K; Sakai T; Ohmori S; Murata K; Takase K; Tameda Y; Nakano T Int J Mol Med; 2002 Mar; 9(3):245-50. PubMed ID: 11836630 [TBL] [Abstract][Full Text] [Related]
5. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection. Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876 [TBL] [Abstract][Full Text] [Related]
6. Milder liver cirrhosis and loss of serum HBeAg do not imply lower risk for hepatocellular carcinoma development in HBV-related cirrhosis. Xu J; Shi J; Wang YP; Lin Y; Chen YX; Lu J; Zeng X; Xie WF Med Sci Monit; 2009 Jun; 15(6):CR274-9. PubMed ID: 19478697 [TBL] [Abstract][Full Text] [Related]
7. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma. Cui R; Wang B; Ding H; Shen H; Li Y; Chen X Chin Med J (Engl); 2002 Jan; 115(1):42-5. PubMed ID: 11930656 [TBL] [Abstract][Full Text] [Related]
8. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma. Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443 [TBL] [Abstract][Full Text] [Related]
9. May plasma cholesterol level be considered a neoplastic marker in liver disease from cirrhosis to hepatocellular carcinoma? Venturini I; Amedei R; Modonesi G; Cosenza R; Miglioli L; Cioni G; Zeneroli ML Ital J Gastroenterol Hepatol; 1999; 31(1):61-5. PubMed ID: 10091105 [TBL] [Abstract][Full Text] [Related]
10. Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study. Mazziotti G; Sorvillo F; Morisco F; Carbone A; Rotondi M; Stornaiuolo G; Precone DF; Cioffi M; Gaeta GB; Caporaso N; Carella C Cancer; 2002 Dec; 95(12):2539-45. PubMed ID: 12467068 [TBL] [Abstract][Full Text] [Related]
11. Clinical feminisation and sex hormone concentrations in Nigerian men with cirrhosis with and without hepatocellular carcinoma. Olubuyide IO; Ola OS Br J Clin Pract; 1994; 48(2):70-2. PubMed ID: 8024993 [TBL] [Abstract][Full Text] [Related]
12. Angiopoietin-2 serum levels are elevated in patients with liver cirrhosis and hepatocellular carcinoma. Scholz A; Rehm VA; Rieke S; Derkow K; Schulz P; Neumann K; Koch I; Pascu M; Wiedenmann B; Berg T; Schott E Am J Gastroenterol; 2007 Nov; 102(11):2471-81. PubMed ID: 17581268 [TBL] [Abstract][Full Text] [Related]
13. Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation. Gambarin-Gelwan M; Wolf DC; Shapiro R; Schwartz ME; Min AD Am J Gastroenterol; 2000 Jun; 95(6):1535-8. PubMed ID: 10894592 [TBL] [Abstract][Full Text] [Related]
16. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal. Shrestha SM; Shrestha S; Shrestha A; Tsuda F; Endo K; Takahashi M; Okamoto H J Gastroenterol Hepatol; 2007 Nov; 22(11):1921-8. PubMed ID: 17914971 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma. Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803 [TBL] [Abstract][Full Text] [Related]
18. Plasma proteasome level is a reliable early marker of malignant transformation of liver cirrhosis. Henry L; Lavabre-Bertrand T; Vercambre L; Ramos J; Carillo S; Guiraud I; Pouderoux P; Bismuth M; Valats JC; Demattei C; Duny Y; Chaze I; Funakoshi N; Bureau JP; Daurès JP; Blanc P Gut; 2009 Jun; 58(6):833-8. PubMed ID: 19201777 [TBL] [Abstract][Full Text] [Related]
19. Serum selenium concentration in patients with liver cirrhosis and hepatocellular carcinoma. Buljevac M; Romić Z; Vucelić B; Banić M; Krznarić Z; Plesko S Acta Med Croatica; 1996; 50(1):11-4. PubMed ID: 8776109 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of lamivudine therapy for decompensated liver cirrhosis due to hepatitis B virus with or without hepatocellular carcinoma. Hiraoka A; Michitaka K; Kumagi T; Kurose K; Uehara T; Hirooka M; Yamashita Y; Kubo Y; Miyaoka H; Iuchi H; Okada S; Ohmoto M; Yamamoto K; Horiike N; Onji M Oncol Rep; 2005 Jun; 13(6):1159-63. PubMed ID: 15870937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]